Stoke therapeutics CMO Barry Ticho sells $27,493 in stock
Related news
- PepsiCo cuts Poppi payout estimate to $12M amid U.S. soda sales slump
-
Why did Longfor shares hit a record low today?
-
Why is BYD stock sliding today?
-
Visa wins China approval to prepare for domestic payments business
- SoftBank, SK Hynix lead Asian tech sell-off amid AI investment concerns
- RBA September Minutes: Unanimous 25bps rate hike to 4.6%, hawkish stance maintained
-
Saudi capital’s airport to remain shut this week as airlines cancel services
-
Morning Bid: The fragile AI trade